Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine

E. Tauber, H. Kollaritsch, F. Von Sonnenburg, M. Lademann, Bernd Jilma*, C. Firbas, T. Jelinek, C. Beckett, J. Knobloch, W. J.H. McBride, E. Schuller, A. Kaltenböck, W. Sun, Arthur G. Lyons

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

87 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine'. Together they form a unique fingerprint.

Medicine & Life Sciences